Like their IDH-mutant counterparts, IDH-wildtype lower-grade astrocytomas (Table 4) include tumors with a WHO histologic grade II or III, however, they have significantly worse progression-free and overall survival intervals after initial diagnosis and surgery [4,7,43]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).